Profitelligence Profitelligence · Filing Ledger Open WST research →

Form 8-K · Current Report · Filed 2024-10-07

West Pharmaceutical Services Announces CTO Resignation

On October 1, 2024, West Pharmaceutical Services, Inc.

Filer
West Pharmaceutical Services Inc. WST · NYSE
Filed
Accession
0000105770-24-000071
CIK
0000105770
Signal
Medium impactHealthcare

Details

announced that Silji Abraham, Senior Vice President & Chief Technology Officer, intends to resign effective December 31, 2024, to pursue other interests. His departure is not due to any disagreements with the company, and he will not receive additional compensation as a result of his resignation.

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

CTO Resignation
Item 9.01

Financial Statements and Exhibits

No viable tag

Market reaction

Close before filing

$296.50

Next session

-3.4%

Since filing

+15.0%

Latest close

$340.96

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from WST reporting the same item, with the next session's move:

About West Pharmaceutical Services Inc.

West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.

Exchange NYSE Industry Medical Instruments & Supplies Company website ↗

Never miss another WST filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts